Immutep Limited
PRRUF
$0.20
-$0.004-1.96%
| Weiss Ratings | PRRUF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | PRRUF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | PRRUF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.31 | |||
| Price History | PRRUF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | -1.96% | |||
| 60-Day Total Return | -1.96% | |||
| 90-Day Total Return | -1.96% | |||
| Year to Date Total Return | -1.96% | |||
| 1-Year Total Return | -16.67% | |||
| 2-Year Total Return | 12.36% | |||
| 3-Year Total Return | -31.98% | |||
| 5-Year Total Return | -9.23% | |||
| 52-Week High % Change | -29.57% | |||
| 52-Week Low % Change | 15.47% | |||
| Price | PRRUF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.28 | |||
| 52-Week Low Price | $0.17 | |||
| 52-Week Low Price (Date) | Jul 24, 2024 | |||
| 52-Week High Price (Date) | Apr 25, 2024 | |||
| Valuation | PRRUF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 265.79M | |||
| Enterprise Value | 166.57M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.02 | |||
| Earnings Per Share Growth | -16.15% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 90.91 | |||
| Price/Book (Q) | 2.73 | |||
| Enterprise Value/Revenue (TTM) | 62.07 | |||
| Price | $0.20 | |||
| Enterprise Value/EBITDA (TTM) | -6.20 | |||
| Enterprise Value/EBIT | -6.08 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | PRRUF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 1.45B | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | PRRUF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 61 2 8315 7003 | |||
| Address | Australia Square Sydney, NSW 2000 | |||
| Website | www.immutep.com | |||
| Country | Australia | |||
| Year Founded | 1987 | |||
| Profitability | PRRUF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -1,021.24% | |||
| Profit Margin | -898.65% | |||
| Management Effectiveness | PRRUF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -20.84% | |||
| Return on Equity | -- | |||
| Income Statement | PRRUF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 3.22M | |||
| Total Revenue (TTM) | 3.22M | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | -27.42M | |||
| EBITDA (TTM) | -32.23M | |||
| EBIT (TTM) | -32.88M | |||
| Net Income (TTM) | -28.93M | |||
| Net Income Avl. to Common (TTM) | -28.93M | |||
| Total Revenue Growth (Q YOY) | 49.11% | |||
| Earnings Growth (Q YOY) | -5.40% | |||
| EPS Diluted (TTM) | -0.02 | |||
| EPS Diluted Growth (Q YOY) | 13.79% | |||
| Balance Sheet | PRRUF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 98.56M | |||
| Cash Per Share (Q) | $0.07 | |||
| Total Current Assets (Q) | 107.53M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 106.73M | |||
| Current Ratio (Q) | 18.863 | |||
| Book Value Per Share (Q) | $0.07 | |||
| Total Assets (Q) | 112.83M | |||
| Total Current Liabilities (Q) | 5.70M | |||
| Total Debt (Q) | 1.04M | |||
| Total Liabilities (Q) | 6.10M | |||
| Total Common Equity (Q) | 106.73M | |||
| Cash Flow | PRRUF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -55.07M | |||
| Cash from Financing (TTM) | 62.66M | |||
| Net Change in Cash (TTM) | -19.87M | |||
| Levered Free Cash Flow (TTM) | -21.57M | |||
| Cash from Operations (TTM) | -29.64M | |||
